Colorectal Cancer News
Most Popular Colorectal Cancer Story
Mixed results for Amgen's cancer drug Vectibix
Amgen is continuing its push to boost Vectibix by narrowing the drug's target market. The drugmaker announced results from a another Phase III trial, this time evaluating Vectibix as a second-line Read more...
Latest Headlines
- December 15, 2010
- August 18, 2009
- December 17, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
